Paxlovid is no longer publicly funded for those who do not qualify for the Ontario Drug Benefit program. Usual process applies for those with private insurance/pay out of pocket.
Paxlovid is now listed on the Ontario Drug Benefit Formulary with Limited Use (LU) criteria for eligible adults with a positive COVID-19 test and symptoms within the past five days who are:
65 years and older, regardless of risk factors or number of vaccine doses (LU 673)
Immunocompromised, regardless of age or number of vaccine doses (LU 674)
Ontario Health notes an uptick in cases of meningococcal disease from Saudi Arabia.
Reminder to recommend patients be vaccinated with a quadrivalent (ACYW) meningococcal vaccine before travelling.
Government funded physiotherapy services no longer require a primary care referral. Ministry of Health memo is available here.
New search toolkits for various EMRs to identify patients in need of a measles vaccination are available. The eHealth Centre of Excellence has more information.
At our May 17, Community of Practice, Dr. Daniel Pepe shared how his clinic manages patient flow by triaging patients in an efficient and patient-centred manner. Additionally, Dr. Ali Damji shared his experience with an AI scribe, which saves him about 7 hours each week.
A practical guide for family physicians and primary care teams to implement sustainable healthcare for serious illness and end of life care is being shared by PEACH.
Additional opportunities from OCFP stakeholders and partners can be viewed here.